In some countries, this medicine may only be approved for veterinary use.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Bone resorption inhibitor
Treatment of Paget's disease
Treatment of lameness in animals
Phosphonic acid, [[(4-chlorophenyl)tio]metylene]bis-
- Acidum tiludronicum (Latin)
- Tiludronsäure (German)
- Acide tiludronique (French)
- Acido tiludronico (Spanish)
- Tiludronic Acid (OS: BAN)
- Tiludronique (acide) (OS: DCF)
- Tiludronate Disodium (OS: USAN)
- Tiludronate Sodium (OS: BANM)
- SR 41319B (IS: SanofiWinthrop)
- Equidronate (veterinary use)
Ceva Animal Health, United Kingdom
HAC Pharma, France; Sanofi Aventis, Spain; Sanofi-Aventis, Australia
- Tildren (veterinary use)
Ceva, Italy; Ceva, Netherlands; Ceva AH, South Africa; Ceva Animal Health, Australia; Ceva Animal Health, United States; Ceva Santé Animale, Austria; Ceva Santé Animale, France; Ceva Santé Animale, Norway
|BAN||British Approved Name|
|BANM||British Approved Name (Modified)|
|DCF||Dénomination Commune Française|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.